FDA inks $49.9 million deal with SAS
SAS, the leader in advanced analytics, will extend a 40-year partnership with the US Food and Drug Administration (FDA) to expand its capabilities in natural language processing, artificial intelligence and machine learning capabilities through the SAS® Viya® platform in support of the FDA's mission as an essential public health agency.